Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener Medizinische Wochenschrift 13-14/2020

28.02.2020 | original article

Psychiatric comorbidities in cancer patients: acute interventions by the psychiatric consultation liaison service

verfasst von: PD Dr. med. Arnim Quante, Kristina Schulz, Maria Fissler

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 13-14/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Aim

The aim of this study was to explore the psychiatric comorbidities in cancer patients examined by the psychiatric consultation liaison services (CLP) in a general hospital. Furthermore, we intended to examine associations between certain cancers types and psychiatric disorders as well as to give an overview of the psychiatric treatments options that were recommended by the CLP.

Methods

This retrospective analysis investigated 119 psychiatric consultations for cancer patients in a one year period. The assessment covered demographics and cancer diagnosis, psychiatric diagnosis and proceedings.

Results

One third of all patients were treated for hematological cancer, followed by lung cancer. Depression was the most common psychiatric disorder. One third of all patients with hematological cancer were diagnosed with depression, followed by delirium. Inpatient psychiatric treatment and psychotherapy were most commonly recommended by the consultant psychiatrist. Furthermore, 80.2% of all patients received recommendations for medication with antidepressants.

Conclusion

Our data showed that the CLP provides an important service of detecting and initiating early and appropriate treatment for cancer patients with comorbid psychiatric disorders by directing patients to the relevant treatment procedure or facility.
Literatur
1.
Zurück zum Zitat Ostuzzi G, Benda L, Costa E, et al. Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: systematic review and meta-analysis. Cancer Treat Rev. 2015;41(8):714–24. PubMed Ostuzzi G, Benda L, Costa E, et al. Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: systematic review and meta-analysis. Cancer Treat Rev. 2015;41(8):714–24. PubMed
2.
Zurück zum Zitat Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev. 2018;4:CD11006. PubMed Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev. 2018;4:CD11006. PubMed
3.
Zurück zum Zitat Mehnert A, Brähler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540–6. PubMed Mehnert A, Brähler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540–6. PubMed
4.
Zurück zum Zitat Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121–30. PubMed Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121–30. PubMed
5.
Zurück zum Zitat Boyes AW, Girgis A, D’Este C, et al. Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6 months after diagnosis. J Affect Disord. 2011;135(1–3):184–92. PubMed Boyes AW, Girgis A, D’Este C, et al. Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6 months after diagnosis. J Affect Disord. 2011;135(1–3):184–92. PubMed
6.
Zurück zum Zitat Grassi L, Caruso R, Hammelef K, et al. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry. 2014;26(1):44–62. PubMed Grassi L, Caruso R, Hammelef K, et al. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry. 2014;26(1):44–62. PubMed
8.
Zurück zum Zitat Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015;152(2):239–46. PubMedPubMedCentral Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015;152(2):239–46. PubMedPubMedCentral
9.
Zurück zum Zitat Singer S, Das-Munshi J, Brähler E. Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol. 2010;21:925–30. PubMed Singer S, Das-Munshi J, Brähler E. Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol. 2010;21:925–30. PubMed
10.
Zurück zum Zitat LeGrand SB. Delirium in palliative medicine: a review. J Pain Symptom Manage. 2012;44:583–94. PubMed LeGrand SB. Delirium in palliative medicine: a review. J Pain Symptom Manage. 2012;44:583–94. PubMed
11.
Zurück zum Zitat Miovic M, Block S. Psychiatric disorders in advanced cancer. Cancer. 2007;110:1665–76. PubMed Miovic M, Block S. Psychiatric disorders in advanced cancer. Cancer. 2007;110:1665–76. PubMed
12.
Zurück zum Zitat Mehta RD, Roth AJ. Psychiatric considerations in the oncology setting. CA Cancer J Clin. 2015;65:299–314. Mehta RD, Roth AJ. Psychiatric considerations in the oncology setting. CA Cancer J Clin. 2015;65:299–314.
13.
Zurück zum Zitat Colleoni M, Mandala M, Peruzzotti G, et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000;356(9238):1326–7. PubMed Colleoni M, Mandala M, Peruzzotti G, et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000;356(9238):1326–7. PubMed
14.
Zurück zum Zitat Arrieta O, Angulo LP, Núñez-Valencia C, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20(6):1941–8. PubMed Arrieta O, Angulo LP, Núñez-Valencia C, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20(6):1941–8. PubMed
15.
Zurück zum Zitat Prieto JM, Blanch J, Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stemcell transplantation. J Clin Oncol. 2002;20(7):1907–17. PubMed Prieto JM, Blanch J, Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stemcell transplantation. J Clin Oncol. 2002;20(7):1907–17. PubMed
16.
Zurück zum Zitat Lloyd-Williams M, Shiels C, Taylor F, et al. Depression—an independent predictor of early death inpatients with advanced cancer. J Affect Disord. 2009;113:127–32. PubMed Lloyd-Williams M, Shiels C, Taylor F, et al. Depression—an independent predictor of early death inpatients with advanced cancer. J Affect Disord. 2009;113:127–32. PubMed
17.
Zurück zum Zitat Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11):1797–810. PubMedPubMedCentral Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11):1797–810. PubMedPubMedCentral
18.
Zurück zum Zitat Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients. A meta-analysis. Cancer. 2009;22:5349–61. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients. A meta-analysis. Cancer. 2009;22:5349–61.
19.
Zurück zum Zitat Brenne E, Loge JH, Kaasa S, et al. Depressed patients with incurable cancer: which depressive symptoms do they experience? Palliat Support Care. 2013;11(6):491–500. PubMed Brenne E, Loge JH, Kaasa S, et al. Depressed patients with incurable cancer: which depressive symptoms do they experience? Palliat Support Care. 2013;11(6):491–500. PubMed
20.
Zurück zum Zitat Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006;28:396–402. PubMed Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006;28:396–402. PubMed
21.
Zurück zum Zitat Shim EJ, Park JH. Suicidality and its associated factors in cancer patients: results of a multi-center study in Korea. Int J Psychiatry Med. 2012;43(4):381–403. PubMed Shim EJ, Park JH. Suicidality and its associated factors in cancer patients: results of a multi-center study in Korea. Int J Psychiatry Med. 2012;43(4):381–403. PubMed
22.
Zurück zum Zitat Zhou H, Xian W, Zhang Y, Yang Y, Fang W, Liu J, et al. Suicide among cancer patients: adolescents and young adult (AYA) versus all-age patients. Ann Transl Med. 2019;7(22):658. PubMedPubMedCentral Zhou H, Xian W, Zhang Y, Yang Y, Fang W, Liu J, et al. Suicide among cancer patients: adolescents and young adult (AYA) versus all-age patients. Ann Transl Med. 2019;7(22):658. PubMedPubMedCentral
23.
Zurück zum Zitat Oberaigner W, Sperner-Unterweger B, Fiegl M, et al. Increased suicide risk in cancer patients in Tyrol/Austria. Gen Hosp Psychiatry. 2014;36:483–7. PubMed Oberaigner W, Sperner-Unterweger B, Fiegl M, et al. Increased suicide risk in cancer patients in Tyrol/Austria. Gen Hosp Psychiatry. 2014;36:483–7. PubMed
24.
Zurück zum Zitat Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–7. PubMed Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–7. PubMed
25.
Zurück zum Zitat American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington D.C.: American Psychiatric Press; 2000. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington D.C.: American Psychiatric Press; 2000.
26.
Zurück zum Zitat IBM Corp. IBM SPSS statistics for Windows, version 21.0. Armonk, NY: IBM Corp; 2012. IBM Corp. IBM SPSS statistics for Windows, version 21.0. Armonk, NY: IBM Corp; 2012.
27.
Zurück zum Zitat Linden W, Vodermaier A, Mackenzie R, et al. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2–3):343–51. PubMed Linden W, Vodermaier A, Mackenzie R, et al. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2–3):343–51. PubMed
28.
Zurück zum Zitat Lu D, Andrae B, Valdimarsdóttir U, Sundström K, Fall K, Sparén P, et al. Psychological distress is associated with cancer-specific mortality among patients with cervical cancer. Cancer Res. 2019;28:canres.0116.2019. Lu D, Andrae B, Valdimarsdóttir U, Sundström K, Fall K, Sparén P, et al. Psychological distress is associated with cancer-specific mortality among patients with cervical cancer. Cancer Res. 2019;28:canres.0116.2019.
31.
Zurück zum Zitat Akechi A, Nakano T, Okamura H, et al. Psychiatric disorders in cancer patients: descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J Clin Oncol. 2001;31(5):188–94. PubMed Akechi A, Nakano T, Okamura H, et al. Psychiatric disorders in cancer patients: descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J Clin Oncol. 2001;31(5):188–94. PubMed
32.
Zurück zum Zitat Andersen BL, Yang HC, Farrar WB, et al. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer. 2008;113:413–20. Andersen BL, Yang HC, Farrar WB, et al. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer. 2008;113:413–20.
33.
Zurück zum Zitat Giese-Davis J, Collie K, Rancourt KM, et al. Decrease in depression symptoms in associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29:413–20. PubMed Giese-Davis J, Collie K, Rancourt KM, et al. Decrease in depression symptoms in associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29:413–20. PubMed
34.
Zurück zum Zitat Sharpe M, Walker J, Holm Hansen C, SMaRT (Symptom Management Research Trials) Oncology‑2 Team, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014;384(9948):1099–108. PubMed Sharpe M, Walker J, Holm Hansen C, SMaRT (Symptom Management Research Trials) Oncology‑2 Team, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014;384(9948):1099–108. PubMed
35.
Zurück zum Zitat Zahid JA, Grummedal O, Madsen MT, Gögenur I. Prevention of depression in patients with cancer: a systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res. 2020;120:113–23. PubMed Zahid JA, Grummedal O, Madsen MT, Gögenur I. Prevention of depression in patients with cancer: a systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res. 2020;120:113–23. PubMed
36.
Zurück zum Zitat Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012;30(11):1187–96. PubMed Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012;30(11):1187–96. PubMed
37.
Zurück zum Zitat Miguel C, Albuquerque E. Drug interaction in psycho-oncology: antidepressants and antineoplastics. Pharmacology. 2011;88:333–9. PubMed Miguel C, Albuquerque E. Drug interaction in psycho-oncology: antidepressants and antineoplastics. Pharmacology. 2011;88:333–9. PubMed
38.
Zurück zum Zitat Laoutidis ZG, Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry. 2013;13(140):1–21. Laoutidis ZG, Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry. 2013;13(140):1–21.
39.
Zurück zum Zitat Rayner L, Price A, Evans A, et al. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev. 2010;3:CD750. Rayner L, Price A, Evans A, et al. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev. 2010;3:CD750.
40.
Zurück zum Zitat Rayner L, Price A, Evans A, et al. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med. 2011;25(1):36–51. PubMed Rayner L, Price A, Evans A, et al. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med. 2011;25(1):36–51. PubMed
41.
Zurück zum Zitat Michelini S, Cassano GB, Frare F, et al. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry. 1996;29:127–34. PubMed Michelini S, Cassano GB, Frare F, et al. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry. 1996;29:127–34. PubMed
42.
Zurück zum Zitat Salzman C. The benzodiazepine controversy: therapeutic effects versus dependence, withdrawal and toxicity. Harv Rev Psychiatry. 1997;4:279–82. PubMed Salzman C. The benzodiazepine controversy: therapeutic effects versus dependence, withdrawal and toxicity. Harv Rev Psychiatry. 1997;4:279–82. PubMed
43.
Zurück zum Zitat Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D, et al. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database Syst Rev. 2019;6:CD1026. PubMed Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D, et al. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database Syst Rev. 2019;6:CD1026. PubMed
44.
Zurück zum Zitat Bonnet U, Richter EL, Isbruch K, Scherbaum N. On the addictive power of gabapentinoids: a mini-review. Psychiatr Danub. 2018;30(2):142–9. PubMed Bonnet U, Richter EL, Isbruch K, Scherbaum N. On the addictive power of gabapentinoids: a mini-review. Psychiatr Danub. 2018;30(2):142–9. PubMed
Metadaten
Titel
Psychiatric comorbidities in cancer patients: acute interventions by the psychiatric consultation liaison service
verfasst von
PD Dr. med. Arnim Quante
Kristina Schulz
Maria Fissler
Publikationsdatum
28.02.2020
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 13-14/2020
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-020-00739-0

Weitere Artikel der Ausgabe 13-14/2020

Wiener Medizinische Wochenschrift 13-14/2020 Zur Ausgabe